Cargando…
Evaluation of cell surface reactive immuno-adjuvant in combination with immunogenic cell death inducing drug for in situ chemo-immunotherapy
Apoptotic cells and cell fragments, especially those produced as a result of immunogenic cell death (ICD), are known to be a potential source of cancer vaccine immunogen. However, due to variation between tumours and between individuals, methods to generate such preparations may require extensive ex...
Autores principales: | Walters, Adam A., Wang, Julie Tzu-Wen, Al-Jamal, Khuloud T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262586/ https://www.ncbi.nlm.nih.gov/pubmed/32243973 http://dx.doi.org/10.1016/j.jconrel.2020.03.029 |
Ejemplares similares
-
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
por: Wang, Hua, et al.
Publicado: (2020) -
Inducing immunogenic cell death in immuno-oncological therapies
por: Ti, Dongdong, et al.
Publicado: (2022) -
Nanoparticle-Mediated In Situ Molecular
Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy
por: Walters, Adam A., et al.
Publicado: (2021) -
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022) -
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2020)